Life Sciences market research reports by DelveInsight

• Surgical Microscopes - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Surgical Microscopes - Market Insights, Competitive Landscape, and Market Forecast - 2030 Surgical Microscopes Market by Type (On Casters, Wall Mounted, Table-top, and Ceiling Mounted), Application (Dental, ENT, Gynecology, Ophthalmology, and Others), End-User (Hospitals, Ambulatory Surgery Centers, ... Read More

• Gastroendoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Gastroendoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2030 Gastroendoscopes Market by Product Type (Surgical Endoscopes, Capsule Endoscopes, Transnasal Gastroscopes, Dual Channel Gastroscopes, and Others), Device Type (Rigid Endoscopes and Flexible Endoscopes), Procedure ( ... Read More

• Angio Suites - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Angio Suites - Market Insights, Competitive Landscape, and Market Forecast - 2030 Angio Suites Market by Type (Single-Plane and Bi-Plane), Application (Angiography, Angioplasty, Stenting, Bypass Surgery, and Others), and Geography (North-America, Europe, Asia-Pacific, and Rest of the World) is expec ... Read More

• CRISPR Therapies- Pipeline Insight, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  CRISPR Therapies- Pipeline Insight, 2024 DelveInsight’s, “CRISPR Therapies- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Dengue Fever- Pipeline Insight, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Dengue Fever- Pipeline Insight, 2024 DelveInsight’s, “Dengue Fever- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Dengue Fever pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. I ... Read More

• Psoriatic Arthritis - Pipeline Insight, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Psoriatic Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Psoriatic Arthritis - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Autoimmune Psychosis – Market Insight, Epidemiology, and Market Forecast – 2034

  Nov 11, 2024  |  Published by: DelveInsight  |  USD 7,950

  Autoimmune Psychosis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight’s “Autoimmune Psychosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Autoimmune Psychosis, historical and forecasted epidemiology as well as the ... Read More

• Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, there were an estimated 42 million prevalent cases of MASH in the 7MM. Out of these, a total of ~15 million cases were diagnosed, and this number is projected to increase by the end of 2034 in t ... Read More

• Pre-Eclampsia - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Pre-Eclampsia - Pipeline Insight, 2024 DelveInsight’s, “Pre-Eclampsia - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Schizophrenia - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Schizophrenia - Pipeline Insight, 2024 DelveInsight’s, “Schizophrenia- Pipeline Insight, 2024” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage product ... Read More

• Type 2 Diabetes - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Type 2 Diabetes - Pipeline Insight, 2024 DelveInsight’s, “Type 2 Diabetes - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Type 2 Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Cutaneous T-cell lymphoma - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Cutaneous T-cell lymphoma - Pipeline Insight, 2024 DelveInsight’s, “Cutaneous T-cell lymphoma- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Cutaneous T-cell lymphoma pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More

• Lou Gehrig’s disease - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Lou Gehrig’s disease - Pipeline Insight, 2024 DelveInsight’s, “Lou Gehrig’s disease - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Lou Gehrig’s disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More

• Myotonic Dystrophy - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Myotonic Dystrophy - Pipeline Insight, 2024 DelveInsight’s, “Myotonic Dystrophy - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 27+ pipeline drugs in Myotonic Dystrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More

• Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast – 2034

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast – 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 191,589 diagnosed prevalent cases of idiopathic inflammatory myositis in the 7MM. Of these, the United States accounted for 4 ... Read More

• Smoking Cessation- Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Smoking Cessation- Pipeline Insight, 2024 DelveInsight’s, “Smoking Cessation- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More

• Lupus Nephritis - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Lupus Nephritis - Pipeline Insight, 2024 DelveInsight’s, “Lupus Nephritis - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 1,028,651 diagnosed prevalent cases of NCFB in the 7MM. Of these, the US accounted for approximately 37% of the cases, EU4 and the ... Read More

• Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Atherosclerotic Cardiovascular Disease (ASCVD) was highest in the US among the 7MM, accounting for approximately USD 12 billion which is further expected to rise at a CAGR of 2. ... Read More

• Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parainfluenza virus infection market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of parainfluenza virus infection in the 7MM is expected to ... Read More

• Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Chronic Obstructive Pulmonary Disease (COPD) market was valued at USD 16,075 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). This growth is primarily d ... Read More

• Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size in the 7MM for ITP was estimated to be nearly USD 4,100 million in 2023, which is expected to grow with a significant CAGR during the forecast period. In 2023, the US accounted for ... Read More

• Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parkinson’s disease Psychosis (PDP) market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of PDP in the 7MM is expected to increase, driven by better ... Read More

• Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to the IgA Nephropathy Foundation, IgA nephropathy is an autoimmune disease that attacks the kidneys and affects blood filtration in the kidneys' small blood vessels. IgA nephropathy occurs when an abn ... Read More

• Myotonic Dystrophy - Epidemiology Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Myotonic Dystrophy - Epidemiology Forecast - 2034 Key Highlights DelveInsight's analysis indicates that there were nearly 54,068 diagnosed prevalent cases of myotonic dystrophy in the United States in 2023. Projections suggest that these cases will continue to rise, with anticipated growth reaching ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >